---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-058990"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:55:06.167845+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sarepta exchanges $313.5M of 1.50% convertible notes due 2024 for common stock

## Summary
- Approximately $313.5M aggregate principal of 1.50% Convertible Senior Notes due 2024 exchanged for shares of common stock.
- Exchange consideration: 12.2589 shares per $1,000 principal plus additional shares based on VWAP formula.
- Exchange expected to close on March 7, 2023; shares issued in private placement to accredited investors.
- Shares will be freely tradable under Rule 144; no cash paid for accrued interest.

## SEC filing metadata
- accession: 0001193125-23-058990
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/0001193125-23-058990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-058990
- JSON: https://secwatch.observer/filing/0001193125-23-058990.json
- Plain text: https://secwatch.observer/filing/0001193125-23-058990.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.